RESUMO
The (diphtheria, tetanus, and pertussis [acellular, component] [DTacP]) vaccine is a combined vaccine designed to prevent three potentially fatal diseases including pertussis, tetanus, and diphtheria in both children and adults. We utilized advanced technology to develop a novel DTacP vaccine that was previously unavailable in China. The nonclinical studies were performed to evaluate the immunogenicity, potential toxicity, and local tolerance of the vaccine in animal models. In the immunogenicity study, three batches of the vaccine were intraperitoneally administered to National Institutes of Health (NIH) mice, resulting in 100% seropositivity for all three batches. Additionally, antibody levels notably increased as the immunization dosage increased. In acute toxicity study, no mortality was observed among the animals during the 14-day observation period, and no abnormalities in clinical signs were reported. Active systemic anaphylaxis assessment in guinea pigs showed no evidence of serious allergic reactions in the vaccine groups. In the repeat-dose toxicity study, where five intramuscular doses were administered every 2 weeks, gross autopsy and histopathological examination revealed no vaccine-related systemic pathological changes in rats, with dose site irritant reactions mostly recovered at the end of recovery period. In conclusion, the vaccine demonstrated good local and systemic tolerance, supporting its clinical development.
RESUMO
The SARS-CoV-2 Omicron variant, which was classified as a variant of concern (VOC) by the World Health Organization on 26 November 2021, has attracted worldwide attention for its high transmissibility and immune evasion ability. The existing COVID-19 vaccine has been shown to be less effective in preventing Omicron variant infection and symptomatic infection, which brings new challenges to vaccine development and application. Here, we evaluated the immunogenicity and safety of an Omicron variant COVID-19 inactivated vaccine containing aluminum and CpG adjuvants in a variety of animal models. The results showed that the vaccine candidate could induce high levels of neutralizing antibodies against the Omicron variant virus and binding antibodies, and significantly promoted cellular immune response. Meanwhile, the vaccine candidate was safe. Therefore, it provided more foundation for the development of aluminum and CpG as a combination adjuvant in human vaccines.
Assuntos
Compostos de Alúmen , Vacinas contra COVID-19 , COVID-19 , Animais , Humanos , Alumínio , SARS-CoV-2 , COVID-19/prevenção & controle , Adjuvantes Imunológicos , Imunidade Celular , Anticorpos Neutralizantes , Vacinas de Produtos Inativados , Anticorpos AntiviraisRESUMO
With unique climate, topography, and vegetation, the Qinghai-Tibet plateau is a special biogeographic region with richness of endemic species. However, the taxonomy and distribution of many insect groups on this plateau are still poorly known. Here, we synthesized a species checklist of subfamily Gomphomastacinae (Orthoptera: Acridoidea: Eumastacidae) for this region, while describing a new species: Myrmeleomastax wideis Qiu, sp. nov.. Images of the new species and the distribution map of all the known species are provided. Type specimens for the new species are deposited in the Zoological and Botanical Museum, Shaanxi Normal University, Xi'an, China (SNNU).